Claret Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$218K Hold
1,853
0.03% 314
2025
Q4
$304K Sell
1,853
-4
-0.2% -$627 0.04% 176
2025
Q3
$248K Sell
1,857
-26
-1% -$3.16K 0.03% 259
2025
Q2
$234K Buy
1,883
+311
+20% +$39.6K 0.03% 286
2025
Q1
$200K Buy
1,572
+1
+0.1% +$154 0.03% 284
2024
Q4
$226K Buy
1,571
+11
+0.7% +$1.58K 0.04% 232
2024
Q3
$232K Buy
+1,560
New +$224K 0.04% 206
2021
Q4
Sell
-732
Closed -$212K 193
2021
Q3
$212K Buy
+732
New +$188K 0.04% 159

Other funds holding RGEN

Claret Asset Management's RGEN Position: Q1 2026 in Review

Claret Asset Management held its Repligen (RGEN) position steady in Q1 2026 at 1,853 shares worth $218K. The position accounts for 0.03% of the portfolio, ranked #314.

Claret Asset Management first reported a position in RGEN in Q3 2021 and has held it in 8 quarters since. The position peaked at $304K in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Claret Asset Management held 1,853 shares of Repligen worth $218K as of Q1 2026.
  • Claret Asset Management left its Repligen share count unchanged in Q1 2026.
  • Repligen made up 0.03% of Claret Asset Management's portfolio in Q1 2026, its #314 holding.
  • Claret Asset Management first reported a position in Repligen in Q3 2021 and has held it in 8 quarters since.
  • Claret Asset Management's Repligen position peaked at $304K in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Claret Asset Management's 13F filing for Q1 2026, filed 11 May 2026.